Biofrontera (BFRI) Net Income Growth (3y) (2023 - 2025)
Biofrontera (BFRI) Net Income Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -17.90% |
| 10 | Biofrontera | 10.83 Mn | 4.42 Mn | 14.09 Mn | 69.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.00% |
| Sep 30, 2025 | -37.35% |
| Jun 30, 2025 | -84.33% |
| Mar 31, 2025 | -40.20% |
| Dec 31, 2024 | 54.17% |
| Sep 30, 2024 | 29.26% |
| Jun 30, 2024 | 58.75% |
| Mar 31, 2024 | -43.47% |
| Dec 31, 2023 | 175.70% |
| Sep 30, 2023 | -28.56% |